Thermo Fisher launches new GC and GC-MS portfolios

By The Science Advisory Board staff writers

March 10, 2022 -- Thermo Fisher Scientific has launched new gas chromatography (GC) and GC-mass spectrometry (GC-MS) instruments, which offer hardware and software updates.

The GC/GC-MS instrument portfolio includes the following new instruments:

  • Thermo Scientific TRACE 1600 Series Gas Chromatograph
  • Thermo Scientific AI/AS 1610 Liquid Autosampler
  • Thermo Scientific ISQ 7610 Single Quadrupole GC-MS
  • Thermo Scientific TSQ 9610 Triple Quadrupole GC-MS/MS

Features of these instruments include unique GC modularity and NeverVent technologies that enable increased instrument uptime by accelerating maintenance operations through user-exchangeable injector and detector modules, and the ability to remove MS ion source, filaments, and analytical column without breaking the vacuum, Thermo Scientific said.

Thermo Fisher receives accolades for contract manufacturing leadership
For the third consecutive year, Thermo Fisher Scientific’s pharma and biotech customers have recognized its contract manufacturing leadership in all six...
Thermo Fisher supports biopharma discovery with extended collaboration
Thermo Fisher Scientific and Symphogen have agreed to continue their collaboration to provide biopharmaceutical discovery and development laboratories...
Thermo Fisher calls for grant proposals for cancer molecular profiling research
Thermo Fisher Scientific is calling for new proposals for its Oncomine Clinical Research Grant. This builds on the company’s continuous work to support...
Thermo Fisher Scientific introduces commercial packaging, distribution services
Thermo Fisher Scientific has launched new integrated commercial packaging and distribution services. Patheon Commercial Packaging Services for Cell and...
Thermo Fisher highlights proteomics at HUPO 2021
Thermo Fisher Scientific plans to highlight its proteomics solutions and collaboration with industry experts at the virtual Human Proteome Organization...

Copyright © 2022

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter